Nitric oxide-induced release of acetylcholine in the nucleus accumbens: Role of cyclic GMP, glutamate, and GABA

Journal of Neurochemistry

Volumn 71, Issue 1, 1998, Pages 266-273

  Prast, H ^a   Tran, M H ^a   Fischer, H ^a   Philippu, A ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Acetylcholine release; Cyclic GMP; Glutamate; Nitric oxide; Nucleus accumbens

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; CYCLIC GMP; GLUTAMIC ACID; NITRIC OXIDE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANNULATION; CHEMICAL ANALYSIS; HORMONE ACTION; MALE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 0031814906     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71010266.x     Document Type: Article

References (46)

1. B receptors differentially regulate striatal acetylcholine release in vivo. Neurosci. Lett. 160, 126-130.
2. Campeau S., Falls W. A., Cullinan W. E., Helmreich D. L., Davis M., and Watson S. J. (1997) Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos. Neuroscience 78, 1087-1104.
3. Collins G. G. and Buckley K. S. (1989) Antagonism of monosynaptic excitations in the mouse olfactory cortex slice by 6,7-dinitro-quinoxaline-2,3-dione. Neuropharmacology 28, 1123-1128.
4. Dauge V., Derrien M., Dureux C., Noble F., Corringer P. J., and Roques B. P. (1992) Study of induced effects by selective cholecystokinin agonists in the nociception and behaviour in rodents. Therapie 47, 531-539.
5. De Boer P., Damsma G., Schram Q., Stoof J. C., Zaagsma J., and Westerink H. C. (1992) The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn Schmiedebergs Arch. Pharmacol. 345, 144-152.
6. Feelisch M. (1981) The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17(Suppl. 3), S25-S33.
7. Fischer H., Prast H., and Philippu A. (1995) Adenosine release in the ventral striatum of the rat is modulated by endogenous nitric oxide. Eur. J. Pharmacol. 275, R5-R6.
8. Garthwaite J., Southam E., Boulton C. L., Nielsen E. B., Schmidt K., and Mayer B. (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48, 184-188.
9. Greenberg L. H., Troyer E., Ferrendelli J. A., and Weiss B. (1973) Enzymatic regulation of the concentration of cyclic GMP in mouse brain. Neuropharmacology 17, 737-745.
10. Guevara-Guzman R., Emson P. C., and Kendrick K. M. (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62, 807-810.
11. 3H]-dopamine from striatal slices. Neuroreport 3, 409-412.
12. Imperato A., Obinu M. Z., Dazzi L., and Gessa G. L. (1994) Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? Eur. J. Pharmacol. 251, 271-279.
13. Kontos H. A. and Wei E. P. (1993) Hydroxyl radical dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke 3, 427-434.
14. Lapper S. R. and Bolam J. P. (1992) Input from the frontal cortex and the parafascial nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience 51, 533-545.
15. Lauth D., Hertting G., and Jackisch R. (1993) Involvement of nitric oxide synthase in 3,4-diaminopyridine-evoked noradrenaline release in rat hippocampus. Eur. J. Pharmacol. 236, 165-166.
16. Lonart G., Wang J., and Johnson K. M. (1992) Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol. 220, 271-272.
17. Manzoni O. and Bockaert J. (1993) Nitric oxide synthase endogenously modulates NMDA receptors. J. Neurochem. 61, 368-370.
18. Maragos W. F. and Silverstein F. S. (1995) Inhibition of nitric oxide synthase activity attenuates striatal malonate lesions in rats. J. Neurochem. 64, 2362-2365.
19. 2+ independent synaptic vesicle release. Neuron 12, 1235-1244.
20. Meffert M. K., Calakos N. C., Scheffer H. R., and Schulman H. (1996) Nitric oxide modulates synaptic vesicle docking/fusion reactions. Neuron 16, 1229-1236.
21. Meredith G. E., Blank B., and Groenewegen H. (1989) The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat. Neuroscience 31, 327-345.
22. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B., and Friedlander M. J. (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263, 973-977.
23. Morley D., Maragos C. M., Zhang X. Y., Boignon M., Wink D. A., and Keefer L. K. (1993) Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilatators. J. Cardiovasc. Pharmacol. 21, 670-676.
24. Mulsch A., Busse R., Liebau S., and Fostermann U. (1988) LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther. 247, 283-287.
25. Nisenbaum E. S., Grace A. A., and Berger T. W. (1992) Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic input-II. In vitro analysis. Neuroscience 48, 579-593.
26. Paxinos G. and Watson H. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
27. Pennartz C. M. A., Groenewegen H. J., and Lopez da Silva F. H. (1994) The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42, 719-761.
28. Philippu A. (1984) Use of push-pull cannulae to determine the release of endogenous neurotransmitters in distinct brain areas of anaesthetized and freely moving animals, in Measurement of Neurotransmitter Release In Vivo (Marsden C. A., ed), pp. 3-37. John Wiley, Chichester.
29. Philippu A. (1985a) The use of push-pull cannulae for superfusing various hypothalamic areas in anaesthetized and conscious, freely moving animals, in In Vivo Perfusion and Release of Neuroactive Substances (Bayon A. and Drucker-Colin R., eds), pp. 221-232. Academic Press, Orlando.
30. Philippu A. (1985b) Analysis of hypothalamic transmitter release during cardiovascular changes. Ann. NY Acad. Sci. 473, 140-150.
31. Philippu A., Prast H., and Singewald N. (1996) Identification and dynamics of neuronal modulation and function in brain structures and nuclei by continuous determination of transmitter release rates using the push-pull superfusion technique: a compelling approach to in vivo brain research. Sci. Pharmacol. 64, 609-618.
32. Prast H. and Philippu A. (1992) Nitric oxide releases acetylcholine in the basal forebrain. Eur. J. Pharmacol 216, 139-140.
33. Prast H., Heistracher M., and Philippu A. (1993) Modulation by dopamine receptors of the histamine release in the rat hypothalamus. Naunyn Schmiedebergs Arch. Pharmacol 347, 301-305.
34. Prast H., Fischer H., Grass K., and Philippu A. (1994) Nitric oxide is a modulator of glutamate and acetylcholine release in the ventral striatum, in Monitoring Molecules in Neuroscience, Proceedings of the 6th International Conference on In Vivo Methods (Louilot A., Durkin T., Spampinato U., and Cador M., eds), pp. 261-262. Seignosse, France.
35. Prast H., Fischer H. P., Werner E., Werner-Felmayer G., and Philippu A. (1995) Nitric oxide modulates the release of acetylcholine in the ventral striatum of the freely moving rat. Naunyn Schmiedebergs Arch. Pharmacol. 352, 67-73.
36. Prast H., Lamberti C., Fischer H., and Philippu A. (1996) Nitric oxide modulates the release of histamine and glutamate in the posterior hypothalamus of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 354, 731-735.
37. Schmidt M. J., Sawyer B. D., Truex L. L., Marshall W. S., and Fleisch J. H. (1985) LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′monophosphate. J. Pharmacol. Exp. Ther. 232, 764-769.
38. Schmidt H. H. W., Gagne G. D., Nakane M., Pollock J. S., Miller M. F., and Murad F. (1992) Mapping of nitric oxide synthase in the rat suggests frequent colocalization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J. Histochem. Cytochem. 40, 1439-1456.
39. Schulz J. B., Mathews R. T., Muqit M. M. K., Browne S. E., and Beal M. F. (1995a) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936-939.
40. Schulz J. B., Mathews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw D. R., Cipolloni P. B., Mecocci P., Kowall N. W., Rosen B. R., and Beal M. F. (1995b) Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15, 8419-8429.
41. Segieth J., Getting S. J., Biggs S. C., and Whitton P. S. (1995) Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats. Neurosci. Lett. 200, 101-104.
42. Silva M. T., Rose S., Hindmarsh J. G., Aislaitner G., Gorrod J. W., Moore P. K., Jenner P., and Marsden C. D. (1995) Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitroindazole. Br. J. Pharmacol. 114, 257-258.
43. Singewald N. and Philippu A. (1998) Release of neurotransmitters in the locus coeruleus. Prog. Neurobiol. (in press).
44. Smolders I., DeKlippel N., Sarre S., Ebinger G., and Michotte Y. (1995) Tonic GABAergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Eur. J. Pharmacol. 284, 83-91.
45. Southam E. and Garthwaite J. (1991) Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci. Lett. 130, 107-111.
46. Vincent S. R. and Kimura H. (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.